Business Description
FibroGen Inc
NAICS : 325412
SIC : 2834
ISIN : US31572Q8087
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.18 | |||||
Equity-to-Asset | -0.62 | |||||
Debt-to-Equity | -0.66 | |||||
Debt-to-EBITDA | -0.69 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -8.35 | |||||
Beneish M-Score | 0.03 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.2 | |||||
3-Year EBITDA Growth Rate | -13.7 | |||||
3-Year EPS without NRI Growth Rate | -10.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 6.7 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.13 | |||||
9-Day RSI | 47.25 | |||||
14-Day RSI | 44.46 | |||||
6-1 Month Momentum % | 302.34 | |||||
12-1 Month Momentum % | -91.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.41 | |||||
Quick Ratio | 1.27 | |||||
Cash Ratio | 0.9 | |||||
Days Inventory | 343.12 | |||||
Days Sales Outstanding | 54.3 | |||||
Days Payable | 223.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.6 | |||||
Shareholder Yield % | -69.24 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.46 | |||||
Operating Margin % | -133.85 | |||||
Net Margin % | -143.56 | |||||
FCF Margin % | -164.33 | |||||
ROA % | -52.19 | |||||
ROIC % | -162.82 | |||||
ROC (Joel Greenblatt) % | -261.06 | |||||
ROCE % | -91.31 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.68 | |||||
EV-to-EBIT | -0.39 | |||||
EV-to-EBITDA | -0.4 | |||||
EV-to-Revenue | 0.52 | |||||
EV-to-FCF | -0.32 | |||||
Earnings Yield (Greenblatt) % | -256.41 | |||||
FCF Yield % | -238.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
FibroGen Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 154.828 | ||
EPS (TTM) (€) | -2.267 | ||
Beta | 1.49 | ||
Volatility % | 178.3 | ||
14-Day RSI | 44.46 | ||
14-Day ATR (€) | 0.123991 | ||
20-Day SMA (€) | 1.07076 | ||
12-1 Month Momentum % | -91.85 | ||
52-Week Range (€) | 0.234 - 17.9 | ||
Shares Outstanding (Mil) | 99.48 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
FibroGen Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
FibroGen Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
FibroGen Inc Frequently Asked Questions
What is FibroGen Inc(STU:1FG)'s stock price today?
When is next earnings date of FibroGen Inc(STU:1FG)?
Does FibroGen Inc(STU:1FG) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |